These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25823912)

  • 1. Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.
    El Hage C; Bédard AM; Samaha AN
    Neuropharmacology; 2015 Dec; 99():715-25. PubMed ID: 25823912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
    Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
    Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.
    Bédard AM; Maheux J; Lévesque D; Samaha AN
    Schizophr Bull; 2013 May; 39(3):692-702. PubMed ID: 22927669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of hippocampal NMDA receptors and nucleus accumbens D1 receptors in the amphetamine-produced conditioned place preference in rats.
    Tan SE
    Brain Res Bull; 2008 Dec; 77(6):412-9. PubMed ID: 18929625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity.
    Charron A; Hage CE; Servonnet A; Samaha AN
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2381-93. PubMed ID: 26508706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic mechanisms underlying the expression of antipsychotic-induced dopamine supersensitivity in rats.
    Servonnet A; Allain F; Gravel-Chouinard A; Hernandez G; Bourdeau Caporuscio C; Legrix M; Lévesque D; Rompré PP; Samaha AN
    Neuropharmacology; 2021 Oct; 197():108747. PubMed ID: 34364897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time.
    Samaha AN; Seeman P; Stewart J; Rajabi H; Kapur S
    J Neurosci; 2007 Mar; 27(11):2979-86. PubMed ID: 17360921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleus accumbens NMDA receptor activation regulates amphetamine cross-sensitization and deltaFosB expression following sexual experience in male rats.
    Beloate LN; Weems PW; Casey GR; Webb IC; Coolen LM
    Neuropharmacology; 2016 Feb; 101():154-64. PubMed ID: 26391065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated ventral tegmental area amphetamine administration alters dopamine D1 receptor signaling in the nucleus accumbens.
    Hu XT; Koeltzow TE; Cooper DC; Robertson GS; White FJ; Vezina P
    Synapse; 2002 Sep; 45(3):159-70. PubMed ID: 12112395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP-dependent protein kinase and reward-related learning: intra-accumbens Rp-cAMPS blocks amphetamine-produced place conditioning in rats.
    Beninger RJ; Nakonechny PL; Savina I
    Psychopharmacology (Berl); 2003 Oct; 170(1):23-32. PubMed ID: 12768275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
    Heidbreder C; Feldon J
    Synapse; 1998 Aug; 29(4):310-22. PubMed ID: 9661249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Wnt signalling dose-dependently impairs the acquisition and expression of amphetamine-induced conditioned place preference.
    Islam F; Xu K; Beninger RJ
    Behav Brain Res; 2017 May; 326():217-225. PubMed ID: 28284949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy.
    Selley DE; Lazenka MF; Sim-Selley LJ; Secor McVoy JR; Potter DN; Chartoff EH; Carlezon WA; Negus SS
    Neuropharmacology; 2020 Apr; 166():107935. PubMed ID: 31917153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
    Gill KM; Cook JM; Poe MM; Grace AA
    Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function.
    Escobar AP; Cornejo FA; Olivares-Costa M; González M; Fuentealba JA; Gysling K; España RA; Andrés ME
    J Neurochem; 2015 Sep; 134(6):1081-90. PubMed ID: 26112331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleus accumbens PKA inhibition blocks acquisition but enhances expression of amphetamine-produced conditioned activity in rats.
    Gerdjikov TV; Giles AC; Swain SN; Beninger RJ
    Psychopharmacology (Berl); 2007 Jan; 190(1):65-72. PubMed ID: 17047929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with the atypical antipsychotic, olanzapine, prevents the expression of amphetamine-induced place conditioning in the rat.
    Mechanic JA; Maynard BT; Holloway FA
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):43-54. PubMed ID: 12551725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.